716
Views
14
CrossRef citations to date
0
Altmetric
Review

An update on new antibiotic prophylaxis and treatment for urinary tract infections in children

, &
Pages 1619-1625 | Received 29 May 2017, Accepted 19 Sep 2017, Published online: 27 Sep 2017

References

  • Alper BS, Curry SH. Urinary tract infection in children. Am Fam Physician. 2005 Dec 15;72(12):2483–2488.
  • Shaikh N, Morone NE, Bost JE, et al. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008 Apr;27(4):302–308.
  • Bhat RG, Katy TA, Place FC. Pediatric urinary tract infections. Emerg Med Clin North Am. 2011 Aug;29(3):637–653.
  • Ramlakhan S, Singh V, Stone J, et al. Clinical options for the treatment of urinary tract infections in children. Clin Med Insights Pediatr. 2014;8:31–37.
  • Coulthard MG, Lambert HJ, Keir MJ. Occurrence of renal scars in children after their first referral for urinary tract infection. BMJ. 1997 Oct 11;315(7113):918–919.
  • Shaikh N, Ewing AL, Bhatnagar S, et al. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics. 2010 Dec;126(6):1084–1091.
  • Faust WC, Diaz M, Pohl HG. Incidence of post-pyelonephritic renal scarring: a meta-analysis of the dimercapto-succinic acid literature. J Urol. 2009 Jan;181(1):290–297. discussion 297–8.
  • Mattoo TK. Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis. 2011 Sep;18(5):348–354.
  • Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child. 2003 May;88(5):444–445.
  • Saltoglu N, Karali R, Yemisen M, et al. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities. Int J Clin Pract. 2015 Jul;69(7):766–770.
  • Rodríguez-Baño J, Navarro MD, Romero L, et al. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006 Dec 1;43(11):1407–1414.
  • Lutter SA, Currie ML, Mitz LB, et al. Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch Pediatr Adolesc Med. 2005 Oct;159(10):924–928.
  • Firoozeh F, Saffari M, Neamati F, et al. Detection of virulence genes in Escherichia coli isolated from patients with cystitis and pyelonephritis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2014 Dec;29:219–222.
  • Hogan J, Mahjoub F, Larakeb AS, et al. Escherichia coli virulence patterns may help to predict vesicoureteral reflux in paediatric urinary tract infections. Acta Paediatr Oslo Nor 1992. 2015 Oct;104(10):e460–5.
  • Gaspari RJ, Dickson E, Karlowsky J, et al. Antibiotic resistance trends in paediatric uropathogens. Int J Antimicrob Agents. 2005 Oct;26(4):267–271.
  • Zorc JJ, Levine DA, Platt SL, et al. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics. 2005 Sep;116(3):644–648.
  • Allocati N, Masulli M, Alexeyev MF, et al. Escherichia coli in Europe: an overview. Int J Environ Res Public Health. 2013 Nov 25;10(12):6235–6254.
  • Glasner C, Albiger B, Buist G, et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2013 Jul 11;18(28):1–7.
  • Sanchez GV, Baird AMG, Karlowsky JA, et al. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients. J Antimicrob Chemother. 2014 Dec;69(12):3259–3262.
  • Linhares I, Raposo T, Rodrigues A, et al. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis. 2013 Jan 18;13:19.
  • Dalhoff A. Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis. 2012;2012:976273.
  • Khoshnood S, Heidary M, Mirnejad R, et al. Drug-resistant gram-negative uropathogens: a review. Biomed Pharmacother Biomedecine Pharmacother. 2017 Aug;11(94):982–994.
  • Leopold SJ, Van Leth F, Tarekegn H, et al. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. J Antimicrob Chemother. 2014 Sep;69(9):2337–2353.
  • Beetz R, Westenfelder M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents. 2011 Dec;38:Suppl:42–50.
  • Agence française de sécurité sanitaire des produits de Santé. Diagnosis and antibiotherapy for community acquired bacterial urinary infections in infants and children. Med Mal Infect. 2007 Oct;37(10):645–663.
  • Launay E, Bingen E, Cohen R, Groupe de Pathologie Infectieuse Pédiatrique. Therapeutics strategies for the management of urinary tract infection in children. Arch Pediatr Organe Off Soc Francaise Pediatr. 2012 Nov; 19(Suppl 3):S109–16.
  • Newman TB. The new American Academy of Pediatrics urinary tract infection guideline. Pediatrics. 2011 Sep;128(3):572–575.
  • Strohmeier Y, Hodson EM, Willis NS, et al. Antibiotics for acute pyelonephritis in children. In The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd, 2014. [cited 2017 Apr 17]. Available from: pub4. doi:10.1002/14651858.CD003772
  • Stein R, Dogan HS, Hoebeke P, et al. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol. 2015 Mar;67(3):546–558.
  • Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999 Jul;104(1 Pt 1):79–86.
  • Montini G, Toffolo A, Zucchetta P, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ. 2007 Aug 25;335(7616):386.
  • Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011 Sep;128(3):595–610.
  • Cheng C-H, Tsau Y-K, Lin T-Y. Effective duration of antimicrobial therapy for the treatment of acute lobar nephronia. Pediatrics. 2006 Jan;117(1):e84–9.
  • Seidel T, Kuwertz-Bröking E, Kaczmarek S, et al. Acute focal bacterial nephritis in 25 children. Pediatr Nephrol Berl Ger. 2007 Nov;22(11):1897–1901.
  • Falagas ME, Vouloumanou EK, Togias AG, et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010 Sep;65(9):1862–1877.
  • Pitout JDD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. 2010 Feb 12;70(3):313–333.
  • Kritsotakis EI, Tsioutis C, Roumbelaki M, et al. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother. 2011 Jun;66(6):1383–1391.
  • Pallett A, Hand K. Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. J Antimicrob Chemother. 2010 Nov;65 Suppl 3:iii25–33.
  • Madhi F, Biscardi S, Bingen E, et al. Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli. Pediatr Infect Dis J. 2013 Jan;32(1):96–97.
  • Gauthier M, Chevalier I, Sterescu A, et al. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Pediatrics. 2004 Oct;114(4):e469–76.
  • Skurnik D, Pier GB, Andremont A. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2010 Feb 11;362(6):555–556. author reply 556–7.
  • Wang -H-HS, Gbadegesin RA, Foreman JW, et al. Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis. J Urol. 2015 Mar;193(3):963–969.
  • Craig JC, Simpson JM, Williams GJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2009 Oct 29;361(18):1748–1759.
  • Mattoo TK, Chesney RW, Greenfield SP, et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) trial. Clin J Am Soc Nephrol CJASN. 2016 Jan 7;11(1):54–61.
  • Canning DA. Re: the Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. J Urol. 2012 Aug;188(2):598–599.
  • Park S, Song SH, Lee C, et al. Bacterial pathogens in first febrile urinary tract infection affect breakthrough infections in infants with vesicoureteral reflux treated with prophylactic antibiotics. Urology. 2013 Jun;81(6):1342–1345.
  • Morris BJ, Wiswell TE. Circumcision and lifetime risk of urinary tract infection: a systematic review and meta-analysis. J Urol. 2013 Jun;189(6):2118–2124.
  • Morris BJ, Wamai RG, Henebeng EB, et al. Estimation of country-specific and global prevalence of male circumcision. Popul Health Metr [Internet]. 2016 Dec; [cited 2017 Sep 14] 14(1): Available from: http://www.pophealthmetrics.com/content/14/1/4
  • Salo J, Uhari M, Helminen M, et al. Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo-controlled trial. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012 Feb 1;54(3):340–346.
  • Afshar K, Stothers L, Scott H, et al. Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial. J Urol. 2012 Oct;188(4 Suppl):1584–1587.
  • Michael M, Hodson EM, Craig JC, et al. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev. 2003;(1):CD003966.
  • Gołębiewska JE, Dębska-Ślizień A, Rutkowski B. Treated asymptomatic bacteriuria during first year after renal transplantation. Transpl Infect Dis Off J Transplant Soc. 2014 Aug;16(4):605–615.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.